• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢评分对胰岛素抵抗预测韩国成年人非酒精性脂肪性肝病发病的作用。

The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.

机构信息

Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.

Department of Medicine, Graduate School of Hanyang University, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2022 Oct;28(4):814-826. doi: 10.3350/cmh.2022.0099. Epub 2022 Jun 9.

DOI:10.3350/cmh.2022.0099
PMID:35680169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9597233/
Abstract

BACKGROUND/AIMS: The early detection and prevention of non-alcoholic fatty liver disease (NAFLD) has been emphasized considering the burden of this disease. Both hepatic and peripheral insulin resistances are strongly associated with NAFLD. We aimed to compare the predictive powers of a hepatic insulin resistance index, the homeostatic model assessment for insulin resistance (HOMA-IR), and a novel peripheral insulin resistance index, the metabolic score for insulin resistance (METS-IR), for the prediction of prevalent and incident NAFLD.

METHODS

Data from 8,360 adults aged 40-69 years at baseline and 5,438 adults without NAFLD who were followed-up at least once after the baseline survey in the Korean Genome and Epidemiology Study were analyzed. The survey was performed biennially, up to the eighth follow-up.

RESULTS

The predictive powers of the METS-IR and HOMA-IR for prevalent NAFLD were not significantly different (area under the receiver operating characteristic [ROC] curve [95% confidence interval]: METS-IR, 0.824 [0.814-0.834]; HOMAIR, 0.831 [0.821-0.842]; P=0.276). The area under the time-dependent ROC curve (Heagerty's integrated area under the curve) of the METS-IR for incident NAFLD was 0.683 (0.671-0.695), significantly higher than that of the HOMA-IR (0.551 [0.539-0.563], P<0.001).

CONCLUSION

The METS-IR is superior to the HOMA-IR for the prediction of incident NAFLD and is not inferior to the HOMA-IR for the prediction of prevalent NAFLD. This suggests that the METS-IR can be a more useful insulin resistance index than the HOMA-IR for the early detection and prevention of NAFLD in Korean population.

摘要

背景/目的:鉴于非酒精性脂肪性肝病(NAFLD)的负担,强调了对其的早期检测和预防。肝和外周胰岛素抵抗与 NAFLD 密切相关。我们旨在比较肝胰岛素抵抗指数、稳态模型评估的胰岛素抵抗(HOMA-IR)和新的外周胰岛素抵抗指数、代谢评分的胰岛素抵抗(METS-IR)对预测现患和新发 NAFLD 的预测能力。

方法

对基线时年龄为 40-69 岁的 8360 名成年人和基线后至少随访一次且无 NAFLD 的 5438 名成年人的数据进行了分析,这些成年人参加了韩国基因组和流行病学研究。该调查每两年进行一次,最多进行八次随访。

结果

METS-IR 和 HOMA-IR 对现患 NAFLD 的预测能力无显著差异(接受者操作特征曲线下面积[95%置信区间]:METS-IR,0.824[0.814-0.834];HOMA-IR,0.831[0.821-0.842];P=0.276)。METS-IR 对新发 NAFLD 的时间依赖性 ROC 曲线下面积(Heagerty 综合曲线下面积)为 0.683(0.671-0.695),显著高于 HOMA-IR(0.551[0.539-0.563],P<0.001)。

结论

METS-IR 对预测新发 NAFLD 优于 HOMA-IR,对预测现患 NAFLD 与 HOMA-IR 无差异。这表明,在韩国人群中,METS-IR 可能比 HOMA-IR 更能作为一种有用的胰岛素抵抗指数,用于 NAFLD 的早期检测和预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/cd666537796b/cmh-2022-0099f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/80e7cbcbf2e1/cmh-2022-0099f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/adfa2c592720/cmh-2022-0099f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/cc45fff27947/cmh-2022-0099f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/c211a72e2638/cmh-2022-0099f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/cd666537796b/cmh-2022-0099f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/80e7cbcbf2e1/cmh-2022-0099f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/adfa2c592720/cmh-2022-0099f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/cc45fff27947/cmh-2022-0099f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/c211a72e2638/cmh-2022-0099f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f1/9597233/cd666537796b/cmh-2022-0099f5.jpg

相似文献

1
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.代谢评分对胰岛素抵抗预测韩国成年人非酒精性脂肪性肝病发病的作用。
Clin Mol Hepatol. 2022 Oct;28(4):814-826. doi: 10.3350/cmh.2022.0099. Epub 2022 Jun 9.
2
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.代谢性胰岛素抵抗评分与非酒精性脂肪性肝病患者发生进展性肝纤维化呈负相关。
Nutrients. 2022 Jul 24;14(15):3039. doi: 10.3390/nu14153039.
3
Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults.METS-IR与HOMA-IR在预测中老年人群新发慢性肾脏病方面的比较。
Diabetol Metab Syndr. 2023 Nov 14;15(1):230. doi: 10.1186/s13098-023-01214-7.
4
Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD.多维度比较腹型肥胖指标与胰岛素抵抗指标用于评估非酒精性脂肪肝。
BMC Public Health. 2024 Aug 9;24(1):2161. doi: 10.1186/s12889-024-19657-6.
5
Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.比较甘油三酯-葡萄糖指数和 HOMA-IR 预测代谢综合征的患病率和发生率。
Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):596-604. doi: 10.1016/j.numecd.2021.11.017. Epub 2021 Dec 7.
6
Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.HOMA-IR和QUICKI在代谢综合征及非酒精性脂肪性肝病诊断中的最佳切点:一项基于人群的研究。
J Diabetes Complications. 2016 Mar;30(2):269-74. doi: 10.1016/j.jdiacomp.2015.11.019. Epub 2015 Dec 2.
7
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
8
Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?HOMA-IR能否作为2型糖尿病成年患者非酒精性脂肪性肝病的潜在筛查检测方法?
Eur J Intern Med. 2017 Jun;41:74-78. doi: 10.1016/j.ejim.2017.03.006. Epub 2017 Mar 7.
9
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.甘油三酯葡萄糖指数优于稳态模型评估胰岛素抵抗预测韩国成年人非酒精性脂肪肝。
Endocrinol Metab (Seoul). 2019 Jun;34(2):179-186. doi: 10.3803/EnM.2019.34.2.179.
10
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.与非糖尿病人群中非酒精性脂肪性肝病相关的胰岛素抵抗标志物。
Sci Rep. 2023 Nov 22;13(1):20470. doi: 10.1038/s41598-023-47269-4.

引用本文的文献

1
The association of the metabolic score for insulin resistance and metabolic dysfunction-related steatosis liver disease: a population-based observational study.胰岛素抵抗代谢评分与代谢功能障碍相关脂肪性肝病的关联:一项基于人群的观察性研究。
Eur J Med Res. 2025 Jul 23;30(1):657. doi: 10.1186/s40001-025-02936-2.
2
Non-linear association between metabolic score for insulin resistance and nonalcoholic fatty liver disease: analysis of US National health and nutrition examination survey data, 2017-2020.胰岛素抵抗代谢评分与非酒精性脂肪性肝病之间的非线性关联:对2017 - 2020年美国国家健康与营养检查调查数据的分析
BMC Endocr Disord. 2025 Jul 14;25(1):172. doi: 10.1186/s12902-025-01988-z.
3

本文引用的文献

1
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.KASL临床实践指南:非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
2
Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea.韩国非酒精性脂肪性肝病患病率的系统评价
Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101526. doi: 10.1016/j.clinre.2020.06.022. Epub 2020 Sep 9.
3
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences.
由代谢综合征胰岛素抵抗(METS-IR)介导的体脂百分比与非酒精性脂肪性肝病(NAFLD)之间的非线性关系:阈值效应和亚组差异。
Sci Rep. 2025 Jul 10;15(1):24917. doi: 10.1038/s41598-025-10765-w.
4
Lessons Learned from Liver-on-Chip Platform.从芯片上肝脏平台获得的经验教训。
Ann Biomed Eng. 2025 Jun 28. doi: 10.1007/s10439-025-03779-y.
5
Commentary on "Preoperative carbohydrate loading reduces perioperative insulin resistance and hastens functional recovery of remnant liver after living donor hepatectomy: an open-label randomized controlled trial".对“术前碳水化合物负荷减轻活体肝移植供体肝切除术后围手术期胰岛素抵抗并加速残余肝脏功能恢复:一项开放标签随机对照试验”的评论
Hepatol Int. 2025 Jun 28. doi: 10.1007/s12072-025-10864-w.
6
Identification of pediatric MASLD using insulin resistance indices.使用胰岛素抵抗指数识别儿童代谢相关脂肪性肝病
JHEP Rep. 2025 Apr 3;7(7):101419. doi: 10.1016/j.jhepr.2025.101419. eCollection 2025 Jul.
7
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases.使用代谢评分和脂质比率预测炎症性肠病患者代谢功能障碍相关脂肪性肝病的发病
J Clin Med. 2025 Apr 25;14(9):2973. doi: 10.3390/jcm14092973.
8
Comparison of the predictive value of TyG index and METS-IR for OSA combined with NAFLD: a retrospective observational study based on a physical examination population.TyG指数和METS-IR对阻塞性睡眠呼吸暂停合并非酒精性脂肪性肝病的预测价值比较:一项基于体检人群的回顾性观察研究
BMC Gastroenterol. 2025 Apr 21;25(1):279. doi: 10.1186/s12876-025-03856-5.
9
Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea.非胰岛素类胰岛素抵抗替代标志物与代谢功能障碍相关脂肪性肝病肝脏相关结局的关联:韩国一项全国性队列研究
BMC Gastroenterol. 2025 Apr 18;25(1):274. doi: 10.1186/s12876-025-03877-0.
10
The association between novel metabolic parameters and all-cause/cardiovascular mortality in patients with metabolic syndrome is modified by age.代谢综合征患者中,新的代谢参数与全因死亡率/心血管死亡率之间的关联会因年龄而改变。
Cardiovasc Diabetol. 2025 Feb 28;24(1):96. doi: 10.1186/s12933-025-02587-x.
代谢风险因素与非酒精性脂肪性肝病(NAFLD)患者发生进展性肝疾病的关系:基于人群的观察性研究的系统评价和荟萃分析。
PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr.
4
Hepatic Insulin Clearance: Mechanism and Physiology.肝脏胰岛素清除:机制与生理学。
Physiology (Bethesda). 2019 May 1;34(3):198-215. doi: 10.1152/physiol.00048.2018.
5
Resolving the Paradox of Hepatic Insulin Resistance.解决肝脏胰岛素抵抗的悖论。
Cell Mol Gastroenterol Hepatol. 2019;7(2):447-456. doi: 10.1016/j.jcmgh.2018.10.016. Epub 2018 Nov 3.
6
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断:
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. doi: 10.2337/dc19-S002.
7
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.全球视角下的非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.
8
High-Carbohydrate Diets and Food Patterns and Their Associations with Metabolic Disease in the Korean Population.韩国人群中高碳水化合物饮食及食物模式与代谢性疾病的关联
Yonsei Med J. 2018 Sep;59(7):834-842. doi: 10.3349/ymj.2018.59.7.834.
9
Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans.比较健康白种人和韩国人之间与葡萄糖稳态相关的胰腺体积和脂肪量。
Diabetes Obes Metab. 2018 Nov;20(11):2642-2652. doi: 10.1111/dom.13447. Epub 2018 Jul 16.
10
METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.METS-IR是一种评估胰岛素敏感性的新指标,可预测内脏肥胖和2型糖尿病的发病风险。
Eur J Endocrinol. 2018 May;178(5):533-544. doi: 10.1530/EJE-17-0883. Epub 2018 Mar 13.